03:25am Tuesday 25 June 2019

Imaging Tests Help Reveal Heart Risks in Patients with Psoriatic Disease

Patients with psoriasis and psoriatic arthritis—collectively termed psoriatic disease—face increased heart risks. A new study published in Arthritis & Rheumatology indicates that ultrasound imaging of the carotid arteries can reveal the extent to which patients’ arteries are clogged and also indicate their risk of experiencing future cardiovascular events.

The findings suggest that combining such imaging data with clinical and laboratory measures of traditional cardiovascular risk factors could improve risk predictions and identify which patients with psoriatic disease might benefit from more intensive heart-protective therapies.

“Ultrasound is widely used in rheumatology settings as a point of care to detect joint inflammation. Our study suggests that ultrasound can also be used to identify patients that are at high cardiovascular risk who may be missed by the conventional methods such as the Framingham risk score,” said senior author Lihi Eder, MD, PhD, of the University of Toronto. “This will allow early intervention, such as initiation of lipid lowering therapy, which will ultimately lower the risk of developing cardiovascular events.”

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/art.40925

About Journal 

Arthritis & Rheumatology, an official journal of the American College of Rheumatology, is a peer-reviewed publication for scientists and clinicians interested in the natural history, pathophysiology, treatment, and outcome of the rheumatic diseases. Arthritis & Rheumatology publishes the highest quality basic and clinical research related to the rheumatic diseases, encompassing a wide range of areas of investigative activity. In addition, the journal publishes review articles, editorials, and other educational material intended for both researchers and clinicians. Serving the worldwide community of rheumatology investigators and clinicians, Arthritis & Rheumatology is known internationally as a top rheumatology research journal.About Wiley

Wiley drives the world forward with research and education. Our scientific, technical, medical, and scholarly journals and our digital learning, certification, and student-lifecycle services and solutions help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company’s website can be accessed at www.wiley.com.

 

 


Share on:
or:

MORE FROM Immune System

Health news